Kerry McEachern, MS, MBA

Kerry serves as vice president, head of program management, program leadership and alliance management at Curie Therapeutics. Prior to joining Curie, she was on the program and alliance management team at Dragonfly Therapeutics and bluebird bio where she led oncology portfolio & program management. Prior to bluebird, Kerry led at research portfolio & operations management across Immunogen’s ADC pipeline and held scientific and project leadership roles at Genzyme/Sanofi. Kerry holds a B.S. and M.S. from UMass Amherst and an MBA from Babson College.